Integra LifeSciences Holdings Corporation announced that the FDA has approved the PMA Supplement for Integra Dermal Regeneration Template (IDRT) for...
The FDA has approved the marketing of the Cobas Integra 800 Tina-quant HbA1cDx assay, from Roche, for the diagnosis of...
Roche announced that its new, dedicated high-throughput HbA1c testing solution for diabetes, the cobas c 513 analyser, is now available...
Treatment of known or suspected cyanide poisoning in all age ranges. Cyanokit is to be administered together with appropriate decontamination and supportive measures (see section 4.4).
Lantheus Medical Imaging has announced that results from its first Phase III study of flurpiridaz F 18 for myocardial perfusion...
A Phase II clinical trial for F 627,recombinant G-CSF from Generon(Shanghai)Corporation, has been started after FDA regulatory clearance. The study...
The FDA has granted approval to EMD Serono for Gonal-f RFF Redi-ject (follitropin alfa injection), a disposable pre-filled drug injector...
Generon Corporation announced that the first pivotal phase III study in the U.S. for F 627 to treat chemotherapy-induced neutropenia...
Generon BioMed announced positive results from a placebo-controlled trial with F 627 (benegrastim), a recombinant human Granulocyte Colony Stimulating Factor...
Background: Indications, efficacy, and safety of plasma products are highly debated. We compared the concentrations of haemostatic proteins and cytokines in solvent/detergent-treated plasma (SDP) and fresh-frozen plasma (FFP).